Markets

Five Prime Therapeutics soars 386% after positive cancer trial results

Five Prime Therapeutics soared as much as 386% on Tuesday after the biotechnology company released positive results for its phase 2 trial evaluating bemarituzumab in stomach cancer. Five Prime’s Phase 2 FIGHT trial met all three primary endpoints of its study, including an improvement in progression-free survival. “These results bring […]
Five Prime Therapeutics soars 386% after positive cancer trial results
Markets

Inovio tanks 40% after pausing coronavirus vaccine trial, trading halted

Inovio Pharmaceuticals tumbled as much as 40% in early Monday trading after the biotech firm announced a temporary hold on its coronavirus vaccine’s phase 2/3 trial. The study is on “partial clinical hold” until questions asked by the Food and Drug Administration are answered, Inovio said in a press release. […]
Inovio tanks 40% after pausing coronavirus vaccine trial, trading halted